机构

• 上海药物研究所 [162]
• 过程工程研究所 [41]
• 合肥物质科学研究院 [40]
• 自动化研究所 [25]
• 深圳先进技术研究院 [14]
• 昆明植物研究所 [9]
• 更多

采集方式

• OAI收割 [356]
• iSwitch采集 [12]

Content Type

• Journal ... [356]
• Thesis [6]
• Conference... [5]
• Project [1]

Issued Date

• 2024 [21]
• 2023 [37]
• 2022 [65]
• 2021 [55]
• 2020 [58]
• 2019 [41]
• 更多

Subject

• Research &... [6]
• Oncology [3]
• Biochemist... [2]
• Biophysics [2]
• Immunology [2]
• Pharmacolo... [2]
• 更多

筛选

Browse/Search Results:  1-10 of 368 Help 条数/页： 5101520253035404550556065707580859095100 排序方式： SelectTitle AscendingTitle DescendingSubmit date AscendingSubmit date DescendingIssue Date AscendingIssue Date DescendingAuthor AscendingAuthor Descending Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 8, 页码: 3643-3660 Authors:  Wang, Jie;  Zhang, Zilong;  Zhuo, Yan;  Zhang, Zhuan;  Chen, Rongrong   |  Favorite  |   Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 7, 页码: 3218-3231 Authors:  Zhang, Wen;  Zhai, Yihui;  Cai, Ying;  Gong, Xiang;  Jiang, Yunxuan   |  Favorite  |   Discovery of Novel 1-Phenylpiperidine Urea-Containing Derivatives Inhibiting β-Catenin/BCL9 Interaction and Exerting Antitumor Efficacy through the Activation of Antigen Presentation of cDC1 Cells 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2024, 页码: 36 Authors:  Zhu, Wenhua;  Liu, Cuiting;  Xi, Kang;  Li, Anqi;  Shen, Li-an   |  Favorite  |   In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors 期刊论文  OAI收割 NANO TODAY, 2024, 卷号: 56, 页码: 13 Authors:  Liu, Xiaoying;  Chen, Fangmin;  Saeed, Madiha;  Li, Xutong;  Zhang, Huijuan   |  Favorite  |   Innovative Drug and Evaluation Innovation Team for Tumor Immunotherapy of Jinan Science and Technology Bureau[RO-MY201712] 项目  OAI收割 项目编号: RO-MY201712, 资助机构: Innovative Drug and Evaluation Innovation Team for Tumor Immunotherapy of Jinan Science and Technology Bureau, 2024- -   |  Favorite  |   Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration 期刊论文  OAI收割 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 卷号: 9, 期号: 1, 页码: 15 Authors:  He, Fenglian;  Wu, Zhongen;  Liu, Chenglong;  Zhu, Yuanyuan;  Zhou, Yan   |  Favorite  |   Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity 期刊论文  OAI收割 CELL REPORTS MEDICINE, 2024, 卷号: 5, 期号: 5, 页码: 20 Authors:  Shi, Wenqiang;  Liu, Nan;  Liu, Zexin;  Yang, Yuqi;  Zeng, Qiongya   |  Favorite  |   Charting new paradigms for CAR-T cell therapy beyond current Achilles heels 期刊论文  OAI收割 FRONTIERS IN IMMUNOLOGY, 2024, 卷号: 15, 页码: 12 Authors:  Li, Ying;  Hu, Zhenhua;  Li, Yuanyuan;  Wu, Xiaoyan   |  Favorite  |   Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis 期刊论文  OAI收割 JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 页码: 11 Authors:  Gong, Chenyuan;  Mu, Hongyan;  Luo, Jiaojiao;  Zhang, Rujun;  Hu, Dan   |  Favorite  |   Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 267, 页码: 13 Authors:  Guan, Dezhong;  Fang, Lincheng;  Feng, Mingshun;  Guo, Shi;  Xie, Lingfeng   |  Favorite  |